Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 

      © 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Finasteride Taj Pharmaceuticals Ltd.

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Finasteride Manufacturers in India Suppliers Finasteride Exporters Distributors Finasteride api active pharmaceuticals ingredients Finasteride manufacturers Side Effects bulk drugs raw material Finasteride companies Side Effects Importers Finasteride Finasteride Exporters Finasteride exporters FDA Finasteride DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Finasteride manufacturing pharmaceutical drugs pharmaceutical intermediates Finasteride pharmaceutical chemicals pharmaceutical raw materials Finasteride active pharmaceutical ingredients Finasteride committee active pharmaceutical ingredients manufacturer Finasteride Active Pharmaceutical Ingredients manufacturer Finasteride exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Finasteride, Finasteride manufacturer India, Finasteride product, Finasteride products, Api preparation, Certificate of Analysis API manufacturer product, Finasteride anti ulcer product, Certificate of Origin COA Finasteride COS Finasteride, pharmaceutical generic, pharmaceutical drug, medical, Finasteride pharma healthcare, pharma patents, contract MSDS manufacturing Trader Finasteride pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Finasteride expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Finasteride DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Finasteride ingredients, api, HIV Finasteride, tablets, capsules, syrup & protein Finasteride powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Finasteride gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Finasteride WHO, UKMHRA Approval

   API >>>
   Pharmaceuticals API List
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us

Finasteride Pharmaceutical-Formulations




HOME >> API >> API List1 >> Finasteride >> Precautions

Formula C23H36N2O2

Finasteride CAS number 98319-26-7

Prior to initiating therapy with Finasteride, appropriate evaluation should be performed to identify other conditions such as infection, prostate cancer, stricture disease, hypotonic bladder or other neurogenic disorders that might mimic BPH.

Patients with large residual urinary volume and/or severely diminished urinary flow should be carefully monitored for obstructive uropathy. These patients may not be candidates for Finasteride therapy.

Caution should be used in the administration of Finasteride in those patients with liver function abnormalities, as Finasteride is metabolized extensively in the liver.
Effects on PSA and Prostate Cancer Detection
No clinical benefit has been demonstrated in patients with prostate cancer treated with Finasteride. Patients with BPH and elevated PSA were monitored in controlled clinical studies with serial PSAs and prostate biopsies. In these BPH studies, Finasteride did not appear to alter the rate of prostate cancer detection, and the overall incidence of prostate cancer was not significantly different in patients treated with Finasteride or placebo.

Finasteride causes a decrease in serum PSA levels by approximately 50% in patients with BPH, even in the presence of prostate cancer. This decrease is predictable over the entire range of PSA values, although it may vary in individual patients. Analysis of PSA data from over 3000 patients in a long-term efficacy and safety study confirmed that in typical patients treated with Finasteride for six months or more, PSA values should be doubled for comparison with normal ranges in untreated men. This adjustment preserves the sensitivity and specificity of the PSA assay and maintains its ability to detect prostate cancer.

Any sustained increases in PSA levels while on Finasteride should be carefully evaluated, including consideration of non-compliance to therapy with Finasteride.

Percent free PSA (free to total PSA ratio) is not significantly decreased by Finasteride. The ratio of free to total PSA remains constant even under the influence of Finasteride. If clinicians elect to use percent free PSA as an aid in the detection of prostate cancer in men undergoing Finasteride therapy, no adjustment to its value appears necessary.

Information Associated with Product:
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo


Api Manufacturing At Taj

Acamprosate Calcium

Clomipramine Hcl

Alendronate Sodium



Clopidogrel Bisulfate



Atomoxetine Hcl



Desmopressin Monoacetate


Divalproex Sodium


Dobutamine Hcl

Bupropion Hcl



Dothiepin Hcl






Escitalopram HBr





Cefuroxime Axetil



Fluticasone Propionate

Citalopram Hbr

Fluvoxamine Maleate

Fosphenytoin Sodium

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap


taj group logo
© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.